Log In
BCIQ
Print this Print this
 

Interleukin-2 (IL-2)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Interleukin-2 (IL-2)

BCIQ
Print ChartPrint this
0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 2 1 0 2 1 0 0 0 0 2 1 0 1 1
Phases of DevelopmentDiscoveryPreclinicalPhase IPhase IIPhase II/IIIPhase IIIMarketed
Autoimmune

0

0

2

1

0

1

1

Cancer

2

1

0

2

1

0

0

Dermatology

0

0

1

0

0

0

0

Endocrine / Metabolic

0

0

0

1

0

0

0

Infectious

0

0

0

1

0

0

0

Inflammation

0

0

0

0

0

1

0




 Products Targeting Interleukin-2 (IL-2)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$13.0M

$13.0M

$953.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today